Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
This compound is a synthetic small molecule belonging to the pyridopyrimidine class. It has the molecular formula C17H20N6O2 and a molecular weight of approximately 340.38 g/mol. The structure features a pyrido[2,3-d]pyrimidine core substituted with two amino groups at positions 2 and 4 and an N-methyl-N-(3',5'-dimethoxybenzyl)amino group at position 6. It is cataloged as an experimental compound in chemical databases but does not have any approved pharmaceutical use or well-characterized mechanism of action reported in public sources. Its primary relevance appears to be as a research tool or chemical probe rather than as a marketed drug or clinical candidate[1][2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 2,4-diamino-6-[N-(3',5'-dimethoxybenzyl)-N-methylamino]pyrido[2,3-d]pyrimidine.